ANG Lifesciences India Limited (BOM:540694)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Pharmaceuticals	899.10M	1.31B	2.07B	3.49B	1.54B
Printing and Packagings	67.63M	183.02M	242.05M	218.97M	-
Inter Segment Revenue	-38.27M	-35.61M	-113.19M	-162.65M	-
Total	928.47M	1.46B	2.20B	3.54B	1.54B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Outside India	50.53M	43.37M	34.11M	-	107.96M
India	848.57M	1.27B	2.04B	-	1.38B
Unallocated	-	-	-	-	51.36M
Total	899.10M	1.31B	2.07B	-	1.54B

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error